Compare CVSA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVSA | XENE |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | Canada |
| Employees | 4996 | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.2B |
| IPO Year | N/A | 2014 |
| Metric | CVSA | XENE |
|---|---|---|
| Price | $116.22 | $58.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | ★ $150.00 | $67.17 |
| AVG Volume (30 Days) | 248.0K | ★ 1.0M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $9.66 | N/A |
| Revenue Next Year | $6.58 | $2,436.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $96.08 | $28.19 |
| 52 Week High | $118.80 | $62.91 |
| Indicator | CVSA | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 61.10 | 61.73 |
| Support Level | $110.97 | $39.93 |
| Resistance Level | $118.80 | $59.44 |
| Average True Range (ATR) | 3.42 | 1.83 |
| MACD | -0.59 | -0.22 |
| Stochastic Oscillator | 67.97 | 72.68 |
Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.